Cygnus Therapeutic Systems of Redwood City, Calif., namedRoger Francis vice president of business development andJames Grady VP of human resources. Francis was director oflicensing and business planning for ICI Americas Inc.Pharmaceutical Group. Grady was responsible for humanresources at Beckman Instruments.

Ronald Hoffman was appointed vice president, preclinicalresearch, at SyStemix Inc. of Palo Alto, Calif. He was a professorof medicine at Indiana University School of Medicine.

Adeza Biomedical of Sunnyvale, Calif., named Robert Hussa vicepresident of research and development. He was divisional vicepresident of imaging and therapeutics research anddevelopment at Hybritech.

Vicki Sato and Patrick Leonard have been named to the boardof directors of the Massachusetts Biotechnology Council. Sato isvice president of research, chief scientific officer and chairmanof the scientific advisory board of Vertex Pharmaceuticals Inc.Leonard is president and CEO of Cambridge Biotech Corp.

Neurocrine Biosciences Inc. of La Jolla, Calif., appointed PaulHawran vice president and chief financial officer. He was vicepresident and treasurer of SmithKline Beecham Corp., the U.S.subsidiary of SmithKline Beecham plc.

Erwin Workman, executive vice president of Idexx LaboratoriesInc. of Westbrook, Maine, was named chief operating officer,and John Deckro, chief financial officer, was named senior vicepresident.

TheraTech Inc. of Salt Lake City appointed C. Gregory Arnoldexecutive director of process engineering. He was vicepresident of operations at Cygnus Therapeutic Systems.

Univax Biologicals of Rockville, Md., named Louis Fries directorof clinical research, effective in June. Fries is deputy director ofthe Center for Immunization Research and associate professorof the departments of Medicine and International Health atJohns Hopkins University.

Argus Pharmaceuticals Inc. of Houston named Rafael Correa-Coronas vice president of clinical development and medicalaffairs. He was director for North America at Zambon Corp.

Biogen Inc. of Cambridge, Mass., named Raymond Cabanodirector of quality and Peter Summerfield director of EuropeanMedical Affairs. Cabano was vice president, internationalquality assurance, at G.D. Searle and Co., and Summerfield wasmedical director for Roche Product Ltd.

Martha Manning was appointed vice president, general counseland corporate secretary of U.S. Bioscience Inc. of WestConshohocken, Pa. She was a general counsel at The WestarInstitute.

Interneuron Pharmaceuticals Inc. of Lexington, Mass., named toits board of directors Harry Gray, former chairman, presidentand CEO of United Technologies Inc.

(c) 1997 American Health Consultants. All rights reserved.